ArticleEuropean journal of radiology open2026
Assessment of late gadolinium enhancement peri-infarct zone in myocardial infarction with in vivo endogenous T1-rho mapping.
Article in European journal of radiology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the diagnostic performance of endogenous T1ρ mapping, compared with native T1 and T2 mapping, for identifying late gadolinium enhancement (LGE)-defined peri-infarct zones in acute ST-elevation myocardial infarction (STEMI) and chronic myocardial infarction (MI). Methods: This retrospective study included 35 patients with acute STEMI, 21 with chronic MI, and 35 healthy controls who underwent cardiac MRI with T1ρ, native T1, and T2 mapping between March 2022 and August 2025. LGE was used to delineate peri-infarct zones in patients with MI. A linear mixed-effects model accounting for within-participant clustering compared T1ρ values across myocardial segments. Receiver operating characteristic analysis was used to assess diagnostic performance. Results: Among the 56 patients with MI (mean age, 57 ± 13 years; 49 men), global T1ρ values were elevated in both acute STEMI and chronic MI compared with controls (both Conclusion: Endogenous T1ρ mapping may provide a contrast-free biomarker for myocardial tissue characterization in MI, with diagnostic performance comparable to T2 in acute STEMI and superior to native T1 and T2 in chronic MI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.